RLYB · ISSUER CIK 1739410
Rallybio Corp
Between Aug 1, 2026 and Oct 29, 2026, 7 Rallybio Corp insiders reported $0.00 of open-market purchases and $10K of sales on SEC Form 4.
↗7 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$10KInsider selling
−$10KNet open-market
Oct 29, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 202617:20 | Oct 27, 2026 | RLYB | Chief Executive Officer, Director | M · Exercise | $6.08 | +33,244 | 148,864 | +29% | $202K | ||
| Oct 28, 202617:03 | Oct 27, 2026 | RLYB | Chief Financial Officer | S · Sell | $16.04 | −599 | 15,551 | -4% | −$10K | ||
| Oct 28, 202617:03 | Oct 26, 2026 | RLYB | Chief Financial Officer | A · Grant | — | +2,500 | 16,150 | +18% | — | ||
| Oct 28, 202617:03 | Oct 26, 2026 | RLYB | Director | M · Exercise | $15.28 | +2,062 | 5,624 | +58% | $32K | ||
| Oct 20, 202617:32 | Oct 16, 2026 | RLYB | Director | M · Exercise | $2.38 | +3,562 | 6,544 | +119% | $8K | ||
| Oct 20, 202617:29 | Oct 16, 2026 | RLYB | Director | M · Exercise | $15.28 | +2,062 | 8,604 | +32% | $32K | ||
| Oct 14, 202616:34 | Oct 12, 2026 | RLYB | Director | M · Exercise | $7.41 | +14,820 | 14,820 | New | $110K | ||
| Oct 13, 202616:50 | Oct 9, 2026 | RLYB | Chief Financial Officer | M · Exercise | $6.08 | +3,910 | 13,650 | +40% | $24K | ||
| Oct 8, 202617:04 | Oct 6, 2026 | RLYB | Chief Executive Officer, Director | M · Exercise | $6.08 | +22,456 | 115,620 | +24% | $137K | ||
| Oct 1, 202617:32 | Sep 29, 2026 | RLYB | Chief Financial Officer | M · Exercise | $6.08 | +5,000 | 9,740 | +105% | $30K | ||
| Sep 28, 202621:00 | Sep 24, 2026 | RLYB | Director | M · Exercise | $6.06 | +12,044 | 12,044 | New | $73K | ||
| Sep 18, 202617:42 | Sep 16, 2026 | RLYB | Director | M · Exercise | $2.38 | +3,562 | 3,562 | New | $8K |